New Options When Diffuse Large B Cell Lymphoma (DLBCL) Doesn't Respond to Treatment

March 22, 2021 Run Time: 54 min

CSC's CEO, Linda Bohannon, RN, BSN, MSM, interviews Kami Maddocks, MD, about the newest treatments for relapsed/refractory Diffuse Large B Cell Lymphoma (DLBCL). They will discuss the latest treatment options, current clinical trials, and self-care during treatment.

You can find this video and more information on these pages:

Read

Diffuse Large B Cell Lymphoma (DLBCL)

Learn about the types of diffuse large B cell lymphoma, risk factors, signs and symptoms, how it is diagnosed and staged...